Avecho Biotechnology Ltd Sustainability Reports
Avecho Biotechnology Limited develops and commercializes innovative human and animal health products using its proprietary Tocopheryl Phosphate Mixture drug delivery system. Its research focus includes the development of specific cannabinoid formulations and soft-gel capsules targeting conditions like insomnia.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
LEI: 529900FA9G9T82C2LV25
FIGI: BBG001SCQ4S3
5 reports from 2019 to 2025
